<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(5)</volume><submitter>Roche SL</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Angiotensin-converting enzyme inhibitors (ACEIs) are a mainstay of medical management in pediatric cardiology. However, there are no data defining how best to initiate and uptitrate the dose of these medications in children.&lt;h4>Methods and results&lt;/h4>Retrospective chart review revealed only 24% of our pediatric cardiology inpatients were discharged on predefined optimal doses of ACEIs and few underwent further dose uptitration in the 8 weeks after hospital discharge. Therefore, 2 alternative protocols for initiation of captopril were compared in a prospective randomized clinical trial. A "rapid uptitration" protocol reached an optimal dose on day 3, whereas the alternative, "prolonged uptitration" protocol, reached an optimal dose on day 9. Forty-6 patients (54% male) w</pubmed_abstract><journal>Journal of the American Heart Association</journal><pagination>e003230</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4889193</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Angiotensin-Converting Enzyme Inhibitor Initiation and Dose Uptitration in Children With Cardiovascular Disease: A Retrospective Review of Standard Clinical Practice and a Prospective Randomized Clinical Trial.</pubmed_title><pmcid>PMC4889193</pmcid><pubmed_authors>Manlhiot C</pubmed_authors><pubmed_authors>Timberlake K</pubmed_authors><pubmed_authors>George K</pubmed_authors><pubmed_authors>Kantor PF</pubmed_authors><pubmed_authors>Wilson J</pubmed_authors><pubmed_authors>Roche SL</pubmed_authors><pubmed_authors>Balasingam M</pubmed_authors><pubmed_authors>McCrindle BW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Angiotensin-Converting Enzyme Inhibitor Initiation and Dose Uptitration in Children With Cardiovascular Disease: A Retrospective Review of Standard Clinical Practice and a Prospective Randomized Clinical Trial.</name><description>&lt;h4>Background&lt;/h4>Angiotensin-converting enzyme inhibitors (ACEIs) are a mainstay of medical management in pediatric cardiology. However, there are no data defining how best to initiate and uptitrate the dose of these medications in children.&lt;h4>Methods and results&lt;/h4>Retrospective chart review revealed only 24% of our pediatric cardiology inpatients were discharged on predefined optimal doses of ACEIs and few underwent further dose uptitration in the 8 weeks after hospital discharge. Therefore, 2 alternative protocols for initiation of captopril were compared in a prospective randomized clinical trial. A "rapid uptitration" protocol reached an optimal dose on day 3, whereas the alternative, "prolonged uptitration" protocol, reached an optimal dose on day 9. Forty-6 patients (54% male) w</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 May</publication><modification>2026-05-30T03:41:30.525Z</modification><creation>2019-03-27T02:14:59Z</creation></dates><accession>S-EPMC4889193</accession><cross_references><pubmed>27207965</pubmed><doi>10.1161/JAHA.116.003230</doi></cross_references></HashMap>